TY - JOUR
T1 - Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores
AU - Rivera, Johanna
AU - Morgenstern, Alfred
AU - Bruchertseifer, Frank
AU - Kearney, John F.
AU - Turnbough, Charles L.
AU - Dadachova, Ekaterina
AU - Casadevall, Arturo
PY - 2014/3
Y1 - 2014/3
N2 - Radioimmunotherapy (RIT) takes advantage of the specificity and affinity of the antigen-antibody interaction to deliver microbicidal radioactive nuclides to a site of infection. In this study, we investigated the microbicidal properties of an alpha particle-emitting 213Bi-labeled monoclonal antibody (MAb), EA2-1 (213Bi-EA2-1), that binds to the immunodominant antigen on Bacillus anthracis spores. Our results showed that dormant spores were resistant to 213Bi-EA2-1. Significant spore killing was observed following treatment with EA2-1 labeled with 300 μCi 213Bi; however, this effect was not dependent on the MAb. In contrast, when spores were germinating, 213Bi-EA2-1 mediated MAb-specific killing in a dose-dependent manner. Dormant spores are very resistant to RIT, and RIT should focus on targeting vegetative cells and germinating spores.
AB - Radioimmunotherapy (RIT) takes advantage of the specificity and affinity of the antigen-antibody interaction to deliver microbicidal radioactive nuclides to a site of infection. In this study, we investigated the microbicidal properties of an alpha particle-emitting 213Bi-labeled monoclonal antibody (MAb), EA2-1 (213Bi-EA2-1), that binds to the immunodominant antigen on Bacillus anthracis spores. Our results showed that dormant spores were resistant to 213Bi-EA2-1. Significant spore killing was observed following treatment with EA2-1 labeled with 300 μCi 213Bi; however, this effect was not dependent on the MAb. In contrast, when spores were germinating, 213Bi-EA2-1 mediated MAb-specific killing in a dose-dependent manner. Dormant spores are very resistant to RIT, and RIT should focus on targeting vegetative cells and germinating spores.
UR - http://www.scopus.com/inward/record.url?scp=84896877101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896877101&partnerID=8YFLogxK
U2 - 10.1128/AAC.01266-13
DO - 10.1128/AAC.01266-13
M3 - Article
C2 - 24379209
AN - SCOPUS:84896877101
SN - 0066-4804
VL - 58
SP - 1813
EP - 1815
JO - Antimicrobial agents and chemotherapy
JF - Antimicrobial agents and chemotherapy
IS - 3
ER -